DJ Abbott Laboratories Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ slid 1.94% to $92.11 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.79% to 7,515.34 and Dow Jones Industrial Average falling 0.26% to 52,498.64.
This was the stock's fourth consecutive day of losses.
Abbott Laboratories closed 33.01% short of its 52-week high of $137.49, which the company achieved on September 22nd.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.31% to $257.77, Pfizer Inc. $(PFE)$ rose 1.28% to $24.48, and Merck & Co. Inc. $(MRK)$ rose 0.40% to $124.03.
Trading volume (11.7 M) remained 1.3 million below its 50-day average volume of 13.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 13, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 13, 2026 16:35 ET (20:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments